Defective antigen presentation resulting from impaired expression of costimulatory molecules in breast cancer

International Journal of Cancer

Volumn 88, Issue 2, 2000, Pages 239-244

  Wolfram, Roswitha M ^a   Budinsky, Alexandra C ^a   Brodowicz, Thomas ^a   Kubista, Marion ^b   Köstler, Wolfgang J ^a   Kichler Lakomy, Christina ^a   Hellan, Minia ^a   Kahlhammer, Gerhard ^a   Wiltschke, Christoph ^a   Zielinski, Christoph C ^a,b,c  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE SUBPOPULATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ADULT; AGED; AGED, 80 AND OVER; ANTIGEN PRESENTATION; ANTIGENS, CD; BREAST NEOPLASMS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMAN; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE ACTIVATION; MIDDLE AGE; MONOCYTES; NEOPLASM STAGING; RECOMBINANT PROTEINS; REFERENCE VALUES; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR;

EID: 0033809037     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20001015)88:2<239::AID-IJC15>3.0.CO;2-Z     Document Type: Article

References (43)

1. Tumor necrosis factor and soluble interleukin-2 receptor: Two immunological biomarkers in female neoplasms
2. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro
3. Tumor necrosis factors alpha and beta in acquired immunodeficiency syndrome (AIDS) and aids-related complex
4. Normal T lymphocyte and monocyte function after minimally invasive surgery
5. Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breast-cancer cells in vitro
6. Involvement of MHC class I molecule and ICAM-1 in the enhancement of adhesion and cytotoxic susceptibility to immune effector cells of tumor cells transfected with the interleukin (IL)-2, IL-4 or IL-6 gene
7. Recombinant tumor necrosis factor receptor p75 fusion protein (TNFR:Fc) alters endotoxin-induced activation of the kinin, fibrinolytic, and coagulation systems in normal humans
8. Borrelia burgdorferi activates nuclear factor-kappa B and is a potent inducer of chemokine and adhesion molecule gene expression in endothelial cells and fibroblasts
9. TNF alpha is an effective therapeutic target for rheumatoid arthritis
10. Transplantation of anergic histoincompatible bone marrow allografts
11. Characteristics of antigen-independent and antigen-dependent interaction of dendritic cells with CD4+ T-cells
12. IFN-gamma priming of monocytes enhances LPS-induced TNF production by augmenting both transcription and MRNA stability
13. The TNF-ligand and receptor superfamilies: Controllers of immunity and the Trojan horses of autoimmune disease?
14. A flow cytometric and immunofluorescence microscopic study of tumor necrosis factor production and localization in human monocytes
15. Induction of CDI 1a/leukocyte function antigen-1 and CD54/intercellular adhesion molecule-1 on hairy cell leukemia cells is accompanied by enhanced susceptibility to T-cell but not lymphokine-activated killer-cell cytotoxicity
16. Tumor-derived factor synergizes with IFN-gamma and LPS, IL-2 or TNF-alpha to promote macrophage synthesis of TNF-alpha and TNF receptors for autocrine induction of nitric oxide synthase and enhanced nitric oxide-mediated tumor cytotoxicity
17. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans
18. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria
19. Cytokines in the induction and expression of T-cell-mediated granuloma formation and protection in the murine model of listeriosis
20. Regulation of T-cell activation by CD28 and CTLA-4
21. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions
22. Immunoregulatory effects of cytokines on natural killer cells
23. Inhibition of mononuclear cell recruitment in aortic intima by treatment with anti-ICAM-1 and anti-LFA-1 monoclonal antibodies in hypercholesterolemic rats: Implications of the ICAM-1 and LFA-1 pathway in athero-genesis
24. Endothelial cell precursors are normal components of human umbilical cord blood
25. Inhibition of NK binding to K562 cells induced by MAb saturation of adhesion molecules on target membrane
26. Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases
27. Effects of the stress response in septic rats and LPS-stimulated alveolar macrophages: Evidence for TNF-alpha posttranslational regulation
28. Tumor necrosis factor induction of endothelial cell surface antigens is independent of protein kinase C activation or inactivation. Studies with phorbol myristate acetate and staurosporine
29. The role of T-cell costimulatory activation pathways in transplant rejection
30. Role of the CTLA-4 receptor in T cell activation and immunity. Physiologic function of the CTLA-4 receptor
31. The role of the endothelium in inflammation and tumor metastasis
32. Shock and tissue injury induced by recombinant human cachectin
33. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
34. Construction and characterization of a recombinant vaccinia virus expressing murine intercellular adhesion molecule-1: Induction and potentiation of antitumor responses
35. Intercellular adhesion molecule-1
36. Expression of the adhesion molecule ICAM-1 and major histocompatibility complex class I antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro
37. The pathophysiology of tumor necrosis factors
38. An in vitro model of T cell activation by autologous cytomegalovirus (CMV)-infected human adult endothelial cells: Contribution of CMV-enhanced endothelial ICAM-1
39. Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: A prospective longitudinal study
40. Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways
41. Contribution of lymphocyte function-associated-1/intercellular adhesion molecule-1 binding to the adhesion/signaling cascade of cytotoxic T lymphocyte activation
42. Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha
43. Impaired production of tumor necrosis factor in breast cancer